The goal of this program is to continue to provide broad-based interdisciplinary cancer research training for five predoctoral and five postdoctoral fellows. Trainees funded by this program will work with two faculty members whose complementary research interests lie in basic sciences, clinical research or population based sciences. In order to obtain funding through this training grant, fellows must submit research proposals relevant to the etiology or treatment of cancer that draw upon expertise found in two or more disciplines. Applications are judged on the research project, cancer relevance, interdisciplinary training potential and the applicants'qualifications. This training program is the centerpiece of an initiative in interdisciplinary cancer research at the Fred Hutchinson Cancer Research Center (FHCRC) and the University of Washington (UW). The long-term goal is to increase the pool of investigators who have training and expertise in cross-disciplinary applications of the rapidly expanding knowledge base in biomedical science relevant to cancer and other human diseases. The research experience will be supported by training in grant and manuscript writing, monthly interdisciplinary research meetings, a wide variety of seminars and informal group meetings. Trainees will meet annually with the grant Steering Committee and present their work annually at a research colloquium. The Steering Committee will also meet annually with mentors and monitor the interdisciplinary training components. An additional component of this program is support of predoctoral students who will obtain an M.S. degree in Epidemiology, concurrent with their Ph.D. training in a basic science. A formal Dual Degree program has been established at UW to allow this interdisciplinary training in an efficient manner. Trainees will be recruited both from the pool of pre- and postdoctoral trainees presently working at the two institutions, as well as from trainees who apply to this innovative program through mailings, informational booths at national meetings, and our web site.
This interdisciplinary training program will increase the pool of cancer researchers with a broad knowledge of the causes and treatments of cancer using basic science, clinical and epidemiological tools. Such well trained scientists will be well poised to make breakthroughs in the eradication of this deadly disease.
|Stewart, Mikaela D; Duncan, Emily D; Coronado, Ernesto et al. (2017) Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms. Protein Sci 26:475-483|
|Morris, Shelli M; Davison, Jerry; Carter, Kelly T et al. (2017) Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms. Int J Cancer 140:853-863|
|Roh-Johnson, Minna; Shah, Arish N; Stonick, Jason A et al. (2017) Macrophage-Dependent Cytoplasmic Transfer during Melanoma Invasion In Vivo. Dev Cell 43:549-562.e6|
|Ronen, Keshet; Dingens, Adam S; Graham, Susan M et al. (2017) Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women. EBioMedicine 18:216-224|
|Driver, Jonathan W; Geyer, Elisabeth A; Bailey, Megan E et al. (2017) Direct measurement of conformational strain energy in protofilaments curling outward from disassembling microtubule tips. Elife 6:|
|Cranmer, L M; Langat, A; Ronen, K et al. (2017) Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs. Int J Tuberc Lung Dis 21:256-262|
|Riggle, Kevin M; Riehle, Kimberly J; Kenerson, Heidi L et al. (2016) Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. Pediatr Res 80:110-8|
|Bender Ignacio, Rachel A; Goldman, Jason D; Magaret, Amalia S et al. (2016) Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons. Infect Agent Cancer 11:7|
|Bender Ignacio, Rachel A; Lee, Jeannette Y; Rudek, Michelle A et al. (2016) Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059. J Acquir Immune Defic Syndr 72:52-7|
|Habenicht, Lauren M; Albershardt, Tina C; Iritani, Brian M et al. (2016) Distinct mechanisms of B and T lymphocyte accumulation generate tumor-draining lymph node hypertrophy. Oncoimmunology 5:e1204505|
Showing the most recent 10 out of 161 publications